The Signature Series Magnum 100
by Progressive Electrical Therapeutics
510(k) K934919
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK934919 | Date6 Apr 1994 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- IPF
- Device Class
- Class II
- Regulation
- 21 CFR Part 890.5850
- Advisory Committee
- Physical Medicine
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 23 Sep 2026
The device is a physical medicine device, as indicated by its advisory committee classification and device type. It is identified as THE SIGNATURE SERIES, MAGNUM 100, a product manufactured by Progressive Electrical Therapeutics.
It received FDA 510(k) clearance under K934919 on April 6, 1994, with a traditional clearance pathway and a substantially equivalent decision. The device is authorized for marketing in the United States, with the manufacturer located in Nevada, Missouri.
Other devices from Progressive Electrical Therapeutics
Questions
AI-generated answers, 23 Sep 2026
What is THE SIGNATURE SERIES, MAGNUM 100 used for?
THE SIGNATURE SERIES, MAGNUM 100 is a physical medicine device, as classified by its advisory committee and device type, intended for use in physical medicine applications based on its FDA 510(k) clearance.
Who manufactures THE SIGNATURE SERIES, MAGNUM 100 and where are they located?
THE SIGNATURE SERIES, MAGNUM 100 is manufactured by Progressive Electrical Therapeutics, located at 200 S. Alma, Nevada, Missouri 64772, United States.
What regulatory clearance does THE SIGNATURE SERIES, MAGNUM 100 have and when was it granted?
THE SIGNATURE SERIES, MAGNUM 100 received FDA 510(k) clearance under K934919 on April 6, 1994, through a traditional clearance pathway with a substantially equivalent decision.